ESR1 and neoplasm: We observed that about one-fifth of ER+ tumor samples were positive for FGF2 expression both epithelial and mesenchymal (Supplementary Fig. 7), whereas over 80% of TNBC samples were positive for FGF2 (Fig. 5A).